|
| 36286845 | Common Germline Risk Variants Impact Somatic Alterations and Clinical Features across Cancers. | Cancer Res | 2023 |
| 37256751 | Lineage skewing and genome instability underlie marrow failure in a zebrafish model of GATA2 deficiency. | Cell Rep | 2023 |
| 36993383 | Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls. | Res Sq | 2023 |
| 37380644 | Author Correction: Germline de novo mutations in families with Mendelian cancer syndromes caused by defects in DNA repair. | Nat Commun | 2023 |
| 37336879 | Germline de novo mutations in families with Mendelian cancer syndromes caused by defects in DNA repair. | Nat Commun | 2023 |
| 37066289 | Risk factors for eight common cancers revealed from a phenome-wide Mendelian randomisation analysis of 378,142 cases and 485,715 controls. | medRxiv | 2023 |
| 36782065 | Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 |
| 36539618 | Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. | Nat Genet | 2023 |
| 35882562 | GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. | Gut | 2023 |
| 33948826 | The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management. | Fam Cancer | 2022 |
| 35709760 | eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35504971 | Publisher Correction: Signatures of TOP1 transcription-associated mutagenesis in cancer and germline. | Nature | 2022 |
| 35467766 | Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome. | Int J Cancer | 2022 |
| 35460607 | Germline MBD4 deficiency causes a multi-tumor predisposition syndrome. | Am J Hum Genet | 2022 |
| 35655252 | Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes. | Genome Med | 2022 |
| 36564402 | Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity. | NPJ Genom Med | 2022 |
| 36108087 | Familial component of early-onset colorectal cancer: opportunity for prevention. | Br J Surg | 2022 |
| 35188551 | Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19. | JAMA Netw Open | 2022 |
| 35140396 | Signatures of TOP1 transcription-associated mutagenesis in cancer and germline. | Nature | 2022 |
| 34761389 | Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. | Br J Haematol | 2022 |
| 34187846 | Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. | Gut | 2022 |
| 34301621 | COVID-19 in children with haematological malignancies. | Arch Dis Child | 2022 |
| 32851660 | Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. | Int J Cancer | 2021 |
| 33558336 | Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response. | Cancer Res | 2021 |
| 33805100 | An Evaluation of the Diagnostic Accuracy of a Panel of Variants in <i>DPYD</i> and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities. | Cancers (Basel) | 2021 |
| 34758253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 |
| 34594041 | Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. | Nat Genet | 2021 |
| 34270794 | Genome-wide association studies of toxicity to oxaliplatin and fluoropyrimidine chemotherapy with or without cetuximab in 1800 patients with advanced colorectal cancer. | Int J Cancer | 2021 |
| 33300568 | Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. | Carcinogenesis | 2021 |
| 32229180 | Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration. | J Mol Diagn | 2020 |
| 31668584 | Modifiable pathways for colorectal cancer: a mendelian randomisation analysis. | Lancet Gastroenterol Hepatol | 2020 |
| 31838077 | Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. | Pharmacol Res | 2020 |
| 31748258 | Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 31822785 | Reply to: "Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient". | J Hum Genet | 2020 |
| 32473682 | COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. | Lancet | 2020 |
| 30649440 | Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer. | J Natl Cancer Inst | 2019 |
| 31530880 | The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression. | Sci Rep | 2019 |
| 31486228 | ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study. | Cancer Med | 2019 |
| 31095950 | A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer. | Gastroenterology | 2019 |
| 30716477 | No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. | Clin Gastroenterol Hepatol | 2019 |
| 28960316 | Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci. | Int J Cancer | 2018 |
| 30177804 | The evolutionary landscape of colorectal tumorigenesis. | Nat Ecol Evol | 2018 |
| 30093612 | Identification of nine new susceptibility loci for endometrial cancer. | Nat Commun | 2018 |
| 30042065 | Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. | Lancet Gastroenterol Hepatol | 2018 |
| 29604063 | Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response. | J Pathol | 2018 |
| 27486097 | Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. | Gut | 2017 |
| 28340513 | Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. | Int J Cancer | 2017 |
| 28829991 | Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis. | Eur J Cancer | 2017 |
| 26691890 | The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer. | J Clin Endocrinol Metab | 2016 |
| 27329137 | Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer. | Nat Commun | 2016 |